Oral hypoglycaemic drugs View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1986

AUTHORS

H. Keen , S. Ng Tang Fui

ABSTRACT

Oral hypoglycaemic agents, principally the sulphonylureas are today widely used in the treatment of patients with non-insulin dependent diabetes mellitus (NIDDM) who make up 75–80% of the total diabetic population. The rationale for their use includes both the short term aims of relief of symptoms and biochemical correction and the longer term aspiration for protection against the long-term complications of the diabetic state, affecting eyes, kidneys, nerves and arteries. The short-term aims are certainly achievable, at least in the short run, but there is conflicting and incomplete evidence as to their preventive efficacy for diabetic complications. The advent of the oral agents has certainly not eradicated them. More... »

PAGES

103-120

Book

TITLE

Pathogenesis and Treatment of Diabetes Mellitus

ISBN

978-94-010-8411-6
978-94-009-4301-8

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-94-009-4301-8_12

DOI

http://dx.doi.org/10.1007/978-94-009-4301-8_12

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034098017


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "Keen", 
        "givenName": "H.", 
        "id": "sg:person.01042343611.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042343611.09"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Ng Tang Fui", 
        "givenName": "S.", 
        "type": "Person"
      }
    ], 
    "datePublished": "1986", 
    "datePublishedReg": "1986-01-01", 
    "description": "Oral hypoglycaemic agents, principally the sulphonylureas are today widely used in the treatment of patients with non-insulin dependent diabetes mellitus (NIDDM) who make up 75\u201380% of the total diabetic population. The rationale for their use includes both the short term aims of relief of symptoms and biochemical correction and the longer term aspiration for protection against the long-term complications of the diabetic state, affecting eyes, kidneys, nerves and arteries. The short-term aims are certainly achievable, at least in the short run, but there is conflicting and incomplete evidence as to their preventive efficacy for diabetic complications. The advent of the oral agents has certainly not eradicated them.", 
    "editor": [
      {
        "familyName": "Radder", 
        "givenName": "J. K.", 
        "type": "Person"
      }, 
      {
        "familyName": "Lemkes", 
        "givenName": "H. H. P. J.", 
        "type": "Person"
      }, 
      {
        "familyName": "Krans", 
        "givenName": "H. M. J.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-94-009-4301-8_12", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-94-010-8411-6", 
        "978-94-009-4301-8"
      ], 
      "name": "Pathogenesis and Treatment of Diabetes Mellitus", 
      "type": "Book"
    }, 
    "keywords": [
      "non-insulin dependent diabetes mellitus", 
      "total diabetic population", 
      "oral hypoglycaemic agents", 
      "oral hypoglycaemic drugs", 
      "relief of symptoms", 
      "dependent diabetes mellitus", 
      "long-term complications", 
      "treatment of patients", 
      "oral agents", 
      "hypoglycaemic agents", 
      "diabetic population", 
      "hypoglycaemic drugs", 
      "diabetes mellitus", 
      "diabetic state", 
      "diabetic complications", 
      "preventive efficacy", 
      "biochemical correction", 
      "complications", 
      "incomplete evidence", 
      "mellitus", 
      "sulphonylureas", 
      "short term", 
      "patients", 
      "nerve", 
      "artery", 
      "symptoms", 
      "agents", 
      "kidney", 
      "short-term aim", 
      "drugs", 
      "efficacy", 
      "treatment", 
      "eyes", 
      "relief", 
      "aspiration", 
      "aim", 
      "population", 
      "term aspiration", 
      "rationale", 
      "evidence", 
      "protection", 
      "use", 
      "advent", 
      "correction", 
      "long-term aspirations", 
      "state", 
      "terms", 
      "today", 
      "run", 
      "short run"
    ], 
    "name": "Oral hypoglycaemic drugs", 
    "pagination": "103-120", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034098017"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-94-009-4301-8_12"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-94-009-4301-8_12", 
      "https://app.dimensions.ai/details/publication/pub.1034098017"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-11-24T21:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/chapter/chapter_63.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-94-009-4301-8_12"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-94-009-4301-8_12'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-94-009-4301-8_12'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-94-009-4301-8_12'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-94-009-4301-8_12'


 

This table displays all metadata directly associated to this object as RDF triples.

120 TRIPLES      22 PREDICATES      75 URIs      68 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-94-009-4301-8_12 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Na64316264166414c9904ac5d5b2d9771
4 schema:datePublished 1986
5 schema:datePublishedReg 1986-01-01
6 schema:description Oral hypoglycaemic agents, principally the sulphonylureas are today widely used in the treatment of patients with non-insulin dependent diabetes mellitus (NIDDM) who make up 75–80% of the total diabetic population. The rationale for their use includes both the short term aims of relief of symptoms and biochemical correction and the longer term aspiration for protection against the long-term complications of the diabetic state, affecting eyes, kidneys, nerves and arteries. The short-term aims are certainly achievable, at least in the short run, but there is conflicting and incomplete evidence as to their preventive efficacy for diabetic complications. The advent of the oral agents has certainly not eradicated them.
7 schema:editor N5bed387d1a7747a286ed720fe85e7d54
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf Nd90687a9e47a4aeda3ebc1aad7ed3d2b
11 schema:keywords advent
12 agents
13 aim
14 artery
15 aspiration
16 biochemical correction
17 complications
18 correction
19 dependent diabetes mellitus
20 diabetes mellitus
21 diabetic complications
22 diabetic population
23 diabetic state
24 drugs
25 efficacy
26 evidence
27 eyes
28 hypoglycaemic agents
29 hypoglycaemic drugs
30 incomplete evidence
31 kidney
32 long-term aspirations
33 long-term complications
34 mellitus
35 nerve
36 non-insulin dependent diabetes mellitus
37 oral agents
38 oral hypoglycaemic agents
39 oral hypoglycaemic drugs
40 patients
41 population
42 preventive efficacy
43 protection
44 rationale
45 relief
46 relief of symptoms
47 run
48 short run
49 short term
50 short-term aim
51 state
52 sulphonylureas
53 symptoms
54 term aspiration
55 terms
56 today
57 total diabetic population
58 treatment
59 treatment of patients
60 use
61 schema:name Oral hypoglycaemic drugs
62 schema:pagination 103-120
63 schema:productId Ne51c8a9d216a4b3e819f6d1bcd03289e
64 Nec04bc357c4845119e6bfa42519ccbfc
65 schema:publisher Nb759c2de41fa4dfabeddbf8566f2458c
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034098017
67 https://doi.org/10.1007/978-94-009-4301-8_12
68 schema:sdDatePublished 2022-11-24T21:19
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher N80c65ebd3db242f28f205340dad9dfb0
71 schema:url https://doi.org/10.1007/978-94-009-4301-8_12
72 sgo:license sg:explorer/license/
73 sgo:sdDataset chapters
74 rdf:type schema:Chapter
75 N0be0b8eda08149b7b83c3d6a59990045 schema:familyName Krans
76 schema:givenName H. M. J.
77 rdf:type schema:Person
78 N442f5590bde5494892f3ddd69da60159 rdf:first Nbd958578786d43f8b8d5f618fc327e86
79 rdf:rest N5f0ee14dd67f456787962435da9a65b7
80 N5bed387d1a7747a286ed720fe85e7d54 rdf:first N83691ded058c4523bb6c529147b6ed1c
81 rdf:rest N442f5590bde5494892f3ddd69da60159
82 N5f0ee14dd67f456787962435da9a65b7 rdf:first N0be0b8eda08149b7b83c3d6a59990045
83 rdf:rest rdf:nil
84 N80c65ebd3db242f28f205340dad9dfb0 schema:name Springer Nature - SN SciGraph project
85 rdf:type schema:Organization
86 N83691ded058c4523bb6c529147b6ed1c schema:familyName Radder
87 schema:givenName J. K.
88 rdf:type schema:Person
89 Na64316264166414c9904ac5d5b2d9771 rdf:first sg:person.01042343611.09
90 rdf:rest Nf7fb5ed0cb04442ab3f018a46b3304cd
91 Nb759c2de41fa4dfabeddbf8566f2458c schema:name Springer Nature
92 rdf:type schema:Organisation
93 Nbd958578786d43f8b8d5f618fc327e86 schema:familyName Lemkes
94 schema:givenName H. H. P. J.
95 rdf:type schema:Person
96 Nbfec915809e344efbb61b66ae5dfa8da schema:familyName Ng Tang Fui
97 schema:givenName S.
98 rdf:type schema:Person
99 Nd90687a9e47a4aeda3ebc1aad7ed3d2b schema:isbn 978-94-009-4301-8
100 978-94-010-8411-6
101 schema:name Pathogenesis and Treatment of Diabetes Mellitus
102 rdf:type schema:Book
103 Ne51c8a9d216a4b3e819f6d1bcd03289e schema:name doi
104 schema:value 10.1007/978-94-009-4301-8_12
105 rdf:type schema:PropertyValue
106 Nec04bc357c4845119e6bfa42519ccbfc schema:name dimensions_id
107 schema:value pub.1034098017
108 rdf:type schema:PropertyValue
109 Nf7fb5ed0cb04442ab3f018a46b3304cd rdf:first Nbfec915809e344efbb61b66ae5dfa8da
110 rdf:rest rdf:nil
111 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
112 schema:name Medical and Health Sciences
113 rdf:type schema:DefinedTerm
114 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
115 schema:name Clinical Sciences
116 rdf:type schema:DefinedTerm
117 sg:person.01042343611.09 schema:familyName Keen
118 schema:givenName H.
119 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042343611.09
120 rdf:type schema:Person
 




Preview window. Press ESC to close (or click here)


...